Liraglutide in United Kingdom: Our Bureau, Bengaluru Friday, February 28, 2025, 15:30 Hrs [IST] Biocon Limited, an innovation-led global ...
1d
HealthDay on MSNGLP-1 Receptor Agonist Use Not Linked to Increased Suicide RiskGlucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...
2d
News Medical on MSNNew study confirms GLP-1 medications are safe for mental health in diabetesResearchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...
Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within 1 year.
Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...
Taiwan: A recent cohort study has highlighted the potential benefits of combining glucagon-like peptide-1 receptor agonists ...
A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.
Expanding coverage and access to GLPs can be beneficial for all with the cooperation of multiple parties in health care.
GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.
While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
This cohort study found no significant association between the preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and short-term postoperative aspiration pneumonia despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results